Credit: Unsplash/CC0 Public Domain Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in doses of 100,000 IU every two weeks significantly reduced disease activity in clinically isolated syndrome and early relapsing‑remitting multiple sclerosis. The study is published in the journal JAMA. Multiple sclerosis (MS) typically starts with an acute episode involving the central nervous system, such as optic neuritis (inflammation ...